Classical vaccines often rely on traditional technologies, such as live attenuated or inactivated pathogens, which carry inherent risks including reduced immunogenicity under certain conditions and potential safety concerns. This has spurred the need for innovative approaches that can provide safer and more effective prophylactic solutions in veterinary medicine.
